Preeclampsia: Should screening and pronostic biomarkers be used in common clinical practice?

Saved in:

Bibliographic Details
Published in:	La Presse médicale (1983) Vol. 48; no. 10; pp. 1032 - 1036
Main Authors:	Hamdi, Safouane M, Sault, Corinne, Piver, Eric, Genoux, Annelise, Masson, Damien, Guibourdenche, Jean
Format:	Journal Article
Language:	French
Published:	France 01-10-2019
Subjects:	Angiogenic Proteins - antagonists & inhibitors Angiogenic Proteins - metabolism Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Aspirin - therapeutic use Biomarkers - blood Biomarkers - metabolism Female Humans Pre-Eclampsia - blood Pre-Eclampsia - diagnosis Pre-Eclampsia - etiology Pre-Eclampsia - physiopathology Pregnancy Pregnancy Trimester, First Pregnancy Trimester, Second Pregnancy Trimester, Third Prevalence Prognosis Vascular Endothelial Growth Factor A - blood Vascular Endothelial Growth Factor A - metabolism
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
ISSN:	2213-0276
DOI:	10.1016/j.lpm.2019.09.029